Literature DB >> 8486789

Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone.

A J Mixson1, P Hauser, G Tennyson, J C Renault, D L Bodenner, B D Weintraub.   

Abstract

Thyroid hormone resistance (THR) is primarily an autosomal dominant inherited disease characterized by resistance of pituitary and peripheral tissues to the action of thyroid hormone. We investigated whether the heterogeneous phenotypic features that occur not only among kindreds but also within the same kindred might be due to the expression of differing ratios of mutant and normal receptors in tissues. Using an allele-specific primer extension method, we determined the relative expression of normal and mutant mRNAs from the fibroblasts of affected and unaffected members of two kindreds with TRH: A-H and N-N. While two affected members of A-H, as expected, had nearly equal amounts of normal and mutant hTR beta mRNA, two other members had mutant mRNA levels that accounted for at least 70% of the hTR beta mRNA. Phenotypic variability within and between kindreds with generalized resistance to thyroid hormone GRTH may be due to this differential expression of the mutant and wild type mRNA. Furthermore, when several clinical parameters of THR were compared in several affected members from two kindreds with GRTH, we found that two cases in one kindred exhibited a high mutant-to-normal hTR beta ratio and had considerably more bone resistance during their development. In certain kindreds with THR, differing ratios of normal and mutant hTR receptors may be age and growth related and may account for the reported attenuation of phenotypic symptoms with age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486789      PMCID: PMC288234          DOI: 10.1172/JCI116458

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine.

Authors:  G E Tennyson; C A Sabatos; K Higuchi; N Meglin; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.

Authors:  A B Shyu; M E Greenberg; J G Belasco
Journal:  Genes Dev       Date:  1989-01       Impact factor: 11.361

3.  Sequences that confer beta-tubulin autoregulation through modulated mRNA stability reside within exon 1 of a beta-tubulin mRNA.

Authors:  D A Gay; T J Yen; J T Lau; D W Cleveland
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

4.  Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone.

Authors:  S Refetoff; L T DeWind; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

5.  A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene.

Authors:  J B Cohen; A D Levinson
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

6.  Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone.

Authors:  T Mitsuhashi; G E Tennyson; V M Nikodem
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Identification of a rat c-erbA alpha-related protein which binds deoxyribonucleic acid but does not bind thyroid hormone.

Authors:  M A Lazar; R A Hodin; D S Darling; W W Chin
Journal:  Mol Endocrinol       Date:  1988-10

8.  Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer.

Authors:  H Drabkin; F T Kao; J Hartz; I Hart; A Gazdar; C Weinberger; R Evans; M Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations.

Authors:  A J Mixson; R Parrilla; S C Ransom; E A Wiggs; J H McClaskey; P Hauser; B D Weintraub
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

10.  Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei.

Authors:  J A Magner; P Petrick; M M Menezes-Ferreira; M Stelling; B D Weintraub
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

View more
  10 in total

1.  Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors.

Authors:  A Dace; L Zhao; K S Park; T Furuno; N Takamura; M Nakanishi; B L West; J A Hanover; S Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 2.  Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K.

Authors:  P Beck-Peccoz; V K Chatterjee; W W Chin; L J DeGroot; J L Jameson; H Nakamura; S Refetoff; S J Usala; B D Weintraub
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

3.  Phenotypic variability in patients with generalised resistance to thyroid hormone.

Authors:  J Pohlenz; S Wirth; A Winterpacht; H Wemme; B Zabel; W Schönberger
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

4.  Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.

Authors:  R Wong; X G Zhu; M A Pineda; S Y Cheng; B D Weintraub
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

5.  Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.

Authors:  M Adams; C Matthews; T N Collingwood; Y Tone; P Beck-Peccoz; K K Chatterjee
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 6.  The syndromes of reduced sensitivity to thyroid hormone.

Authors:  Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Biochim Biophys Acta       Date:  2012-08-16

7.  Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462.

Authors:  A Cama; M L Sierra; T Kadowaki; H Kadowaki; M J Quon; H W Rüdiger; M Dreyer; S I Taylor
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

8.  Syndrome of Reduced Sensitivity to Thyroid Hormones: Two Case Reports and a Literature Review.

Authors:  Anastasios Anyfantakis; Dimitrios Anyfantakis; Irene Vourliotaki
Journal:  Case Rep Endocrinol       Date:  2016-09-28

Review 9.  Resistance to Thyroid Hormone Beta: A Focused Review.

Authors:  Theodora Pappa; Samuel Refetoff
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-31       Impact factor: 5.555

10.  Tissue sensitivity to thyroid hormones may change over time.

Authors:  Giorgio Radetti; Franco Rigon; Alessandro Salvatoni; Irene Campi; Tiziana De Filippis; Valentina Cirello; Silvia Longhi; Fabiana Guizzardi; Marco Bonomi; Luca Persani
Journal:  Eur Thyroid J       Date:  2022-02-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.